HOUSTON and VANCOUVER , April 26, 2018 /CNW/ - ESSA Pharma Inc. (TSX-V: EPI, NASDAQ: EPIX) ("ESSA" or the "Company"), a pharmaceutical company focused on the development of novel small molecule drugs for the treatment of prostate cancer, today announced that David R. Parkinson , President and Chief Executive Officer, will present at the Bloom Burton & Co.
Healthcare Investor Conference 2018 on Wednesday, May 2 nd, at 10:00am Eastern Time , at the Sheraton Centre Toronto Hotel in Toronto, Canada .ESSA to present at Bloom Burton & Co. Healthcare Investor Conference 2018
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться